Consensus statement for the diagnosis and treatment of drug-induced lung injuries. - Abstract
- Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …

Lung injury is an increasing cause of morbidity and mortality in patients treated with cytotoxic
and noncytotoxic drugs. Prompt diagnosis is important because early drug-induced lung …

Abstract Treatment of patients often includes the administration of medications and
sometimes radiation. While the intent is to treat an underlying condition, in some cases …

An increasing number of drugs are recognized to induce distinctive patterns of infiltrative
lung disease (ILD), ranging from benign infiltrates to life-threatening adult respiratory …

Diagnosing drug-induced pulmonary disease remains a challenge for all pulmonologists.
Keeping up with what is new in this field is also a challenge. This review is intended for the …

The above authors have founded a clinical study group known as the GEPPI (Groupe
d'Etudes de la Pathologie Pulmonaire Iatrogene. Address: Professor Ph. Camus, Service de …

Drug-induced disease of any system or organ can be associated with high morbidity and
mortality, and it is tremendously costly to the health care of our country. More than 100 …

Numerous pharmacologic agents used in the treatment of cancer have been linked to
pulmonary toxic side effects. Mechanisms of damage by these drugs include direct …

Drug-induced lung disease presents several diagnostic and therapeutic problems to the
clinician. This is especially true in the case of lung disease associated with antirheumatic …

The syndrome of noncardiogenic pulmonary edema manifests as acute respiratory distress
occurring over several hours. In most instances this is due to capillary endothelial injury …